Login / Signup

Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.

Esperanza Martin-SanchezLaura Blanco-FernándezPeter S KimKamlesh BishtHongfang WangHelgi Van de VeldeTomas JelinekCatia SimoesFelipe ProsperJesús San F MiguelAna AlfonsoJuan-Miguel BerguaRebeca Rodriguez-VeigaSusana VivesDavid Martínez-CuadrónPau MontesinosJuan José LahuertaAintzane Zabaleta
Published in: Blood advances (2024)
Keyphrases
  • acute myeloid leukemia
  • nk cells
  • physical activity
  • cancer therapy
  • middle aged